Curia Global, Inc., a leading contract research, development and manufacturing organization, announced that Philip Macnabb has stepped down as CEO effective as of September 30, 2026. The Company’s search for a new CEO has been underway, and the Company has established the Office of the CEO to oversee the executive team in the interim.
The Office of the CEO will be comprised of Daniel Silvers (Chair of the Company’s Transaction Committee of the Board; Managing Member at Matthews Lane Capital Partners LLC), Brian Teets (incoming Chief Transformation Officer; Managing Directorat Alvarez & Marsal) and Gerald Auer (Curia Chief Financial Officer).
Throughout this transition, Curia remains focused on its partnerships with customers as it continues to help advance life-changing therapies to patients.